| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/07/1992 | CA1304704C Production of interferon gamma |
| 07/07/1992 | CA1304703C Molecules useful for detecting nucleic acid sequences |
| 07/05/1992 | WO1992012262A1 Dna sequences related to isolated fragile x syndrome |
| 07/05/1992 | WO1992012169A1 Pseudomonas peptide composition and method for producing the same |
| 07/05/1992 | WO1992011874A1 Tumor susceptible non-human animals |
| 07/05/1992 | CA2098827A1 Tumor susceptible non-human animals |
| 07/05/1992 | CA2094938A1 Dna sequences related to isolated fragile x syndrome |
| 07/03/1992 | WO1992012258A1 Immortalized human cell lines |
| 07/03/1992 | WO1992012237A1 Fusions of a viral protein and a destructive enzyme |
| 07/03/1992 | CA2099774A1 Immortalized human cell lines |
| 07/02/1992 | DE4041045A1 Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen Two-phase systems for the production and presentation of foreign antigen in hybrid live vaccines |
| 07/01/1992 | EP0493115A2 DNA isolation method |
| 07/01/1992 | EP0493060A2 Production method of d-pantothenic acid and plasmids and microorganisms thereof |
| 07/01/1992 | EP0493037A2 Method of treating thromboembolic disorders |
| 07/01/1992 | EP0492964A2 Cloning and expression of Borrelia lipoproteins |
| 07/01/1992 | EP0492920A1 Chimaeric influenza-HIV vaccine |
| 07/01/1992 | EP0492614A2 Epitheliocyte growth accelerator |
| 07/01/1992 | EP0492536A2 Method for the production of pathogen resistant plants |
| 07/01/1992 | EP0492530A1 Monoclonal antibodies which bind mannose binding protein |
| 07/01/1992 | EP0492525A2 Babesial protease antigen |
| 07/01/1992 | EP0492500A2 Protecting plasmodium falciparum hybrid proteins, containing partial sequences of malaria antigens HRPII and SERP |
| 07/01/1992 | EP0492448A1 Monoclonal antibodies against human tumor necrosis factor alpha |
| 07/01/1992 | EP0492409A1 Human monoclonal antibody |
| 07/01/1992 | EP0492274A2 An asporogenous strain of bacillus subtilis and its use as a host for the preparation of heterologous products |
| 07/01/1992 | EP0492214A2 Human Interleukin-5 receptor |
| 07/01/1992 | EP0492179A2 Avian growth hormone receptor and binding protein |
| 07/01/1992 | EP0492113A2 Herbicide resistant AHAS deletion mutants |
| 07/01/1992 | EP0491888A1 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
| 07/01/1992 | EP0491875A1 Recombinant dna method and vectors for use therein. |
| 07/01/1992 | EP0491867A1 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer. |
| 07/01/1992 | EP0491859A1 TREPONEMA HYODYSENTERIAE ANTIGENS HAVING A MOLECULAR WEIGHT OF 39kDa AND DNA ENCODING THEREFOR |
| 07/01/1992 | EP0491849A1 A method for the purification of transforming growth factor (tgf-). |
| 07/01/1992 | EP0491780A1 A membrane associated protein from plants which has nitrate reductase activity |
| 07/01/1992 | EP0491743A1 Polygalacturonase gene from erwinia carotovora and its molecular cloning |
| 07/01/1992 | EP0491739A1 Multi-functional enzymes including derivable 2',3'-didesoxyribofuranoside triphoshpates |
| 07/01/1992 | EP0491733A1 Somatic embryogenesis of squash. |
| 06/30/1992 | US5126439 Artificial dna base pair analogues |
| 06/30/1992 | US5126434 Monoclonal antibody specific for a human macrophage chemotactic factor |
| 06/30/1992 | US5126323 Homogeneous purified k-fgf and compositions containing the same |
| 06/30/1992 | US5126322 Pancreatic secretory tryspin inhibitor and variants thereof produced by a recombinant host therefore and pharmaceutical use thereof |
| 06/30/1992 | US5126270 Enzyme amplification and purification |
| 06/30/1992 | US5126263 Utilization of plant protoplasts |
| 06/30/1992 | US5126260 Gene therapy for genetic blood disorders |
| 06/30/1992 | US5126256 Recombinant cloning vector |
| 06/30/1992 | US5126252 Production of bovine and porcine growth hormones |
| 06/30/1992 | US5126251 Genetic engineering |
| 06/30/1992 | US5126249 Enzymatic removal of a protein amino-terminal sequence |
| 06/30/1992 | US5126240 Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i |
| 06/30/1992 | US5126239 Reacting nucleic acids with oligonucleotides having more than seven units, amplification, comparing reaction products |
| 06/30/1992 | US5126134 Pharmaceutically active combination |
| 06/30/1992 | US5126130 Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a |
| 06/30/1992 | CA1304288C Cell-free t cell antigen receptor and its clinical utilities |
| 06/29/1992 | WO1992012250A1 Stable transformation of maize cells by electroporation |
| 06/29/1992 | WO1992012177A1 Novel megakaryocyte amplifier and production thereof |
| 06/29/1992 | CA2097817A1 Stable transofrmation of maize cels by electroporation |
| 06/29/1992 | CA2073177A1 Megakaryocyte potentiator and method for producing the same |
| 06/29/1992 | CA2058351A1 Avian growth hormone receptor and binding protein |
| 06/28/1992 | CA2058349A1 Herbicide resistant ahas deletion mutants |
| 06/28/1992 | CA2058003A1 Human-interleukin-5 receptor |
| 06/27/1992 | WO1992012249A1 Control of fruit ripening and senescence in plants |
| 06/27/1992 | CA2096637A1 Control of fruit ripening and senescence in plants |
| 06/27/1992 | CA2057266A1 Dna isolation method |
| 06/25/1992 | WO1992010756A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
| 06/25/1992 | WO1992010755A1 Proteins with changed epitopes and methods for the production thereof |
| 06/25/1992 | WO1992010591A1 Chimeric chains for receptor-associated signal transduction pathways |
| 06/25/1992 | WO1992010583A1 G protein-coupled glutamate receptors |
| 06/25/1992 | WO1992010581A1 IMPROVED SACCHARIFICATION OF CELLULOSE BY CLONING AND AMPLIFICATION OF THE β-GLUCOSIDASE GENE OF TRICHODERMA REESEI |
| 06/25/1992 | WO1992010579A1 PROCESS FOR PRODUCING D-α-AMINO ACID |
| 06/25/1992 | WO1992010578A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | WO1992010574A1 Inhibition of human immunodeficiency virus by an adeno-associated virus gene for human cells |
| 06/25/1992 | WO1992010573A1 Methods and compositions for the suppression of neu mediated transformation |
| 06/25/1992 | WO1992010569A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine |
| 06/25/1992 | WO1992010568A1 Dna which codes for neurotrophic activity inhibitor and use thereof |
| 06/25/1992 | WO1992010567A1 Synthetic bioadhesive polypeptide |
| 06/25/1992 | WO1992010566A1 In-situ hybridization probes for identification and banding of specific human chromosomes and regions |
| 06/25/1992 | WO1992010563A1 Immortalized cell lines and applications thereof, especially for the production of differentiated cells |
| 06/25/1992 | WO1992010561A1 Recombinant cells that highly express chromosomally-integrated heterologous genes |
| 06/25/1992 | WO1992010519A1 A novel protein tyrosine kinase |
| 06/25/1992 | WO1992010513A1 Subunit papillomavirus vaccine and peptides for use therein |
| 06/25/1992 | WO1992010511A1 Compounds and compositions which inhibit bone resorption |
| 06/25/1992 | WO1992008731A3 T-cadherin adhesion molecule |
| 06/25/1992 | DE4041464A1 5-ht(pfeil abwaerts)1(pfeil abwaerts)-rezeptor 5-ht (Down Arrow) 1 (down arrow) receptor |
| 06/25/1992 | DE4041304A1 Von strukturproteinen des hepatitis c-virus abgeleitete polypeptide, testkits, die diese polypeptide enthalten und impfstoffe gegen infektionen von hepatitis c-viren Of structural proteins of the hepatitis C virus-derived polypeptides, test kits containing such polypeptides, and vaccines against infection by hepatitis C virus |
| 06/25/1992 | CA2614365A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | CA2098292A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | CA2098188A1 Sperm cell surface protein ph-20 use in a contraceptive vaccine |
| 06/25/1992 | CA2097935A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
| 06/25/1992 | CA2077350A1 Dna coding for growth-inhibitory factor and use thereof |
| 06/25/1992 | CA2058079A1 Method of treating thromboembolic disorders |
| 06/25/1992 | CA2057963A1 Chimaeric influenza-hiv vaccine |
| 06/25/1992 | CA2057761A1 Protective plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens hrpii and serp, the preparation and use thereof |
| 06/25/1992 | CA2057675A1 Peptide inhibitors of ras-gap interaction |
| 06/25/1992 | CA2056118A1 Monoclonal antibodies which bind mannose binding protein |
| 06/24/1992 | EP0491351A2 Chimeric antibodies and their use |
| 06/24/1992 | EP0491077A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 06/24/1992 | EP0491032A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
| 06/24/1992 | EP0490975A1 Interleukin-4 receptors |
| 06/24/1992 | EP0490951A1 Fragments of nucleic acids derived from an appropriate mycobacteria genome, their applications in the diagnosis of mycobateria infections and plasmides containing said fragments. |
| 06/24/1992 | EP0481069A4 Method for reducing carryover contamination in an amplification procedure |
| 06/24/1992 | EP0462207A4 Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression |